Kazia Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZIA and other ETFs, options, and stocks.About KZIA
Kazia Therapeutics Ltd. is an oncology-focused biotechnology company, which engages in the business of pharmaceutical drug development. It focuses on its Paxalisib program, which is designed to treat brain cancer.
CEOJohn E. Friend
CEOJohn E. Friend
Employees—
Employees—
HeadquartersSydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded1994
Founded1994
Employees—
Employees—
KZIA Key Statistics
Market cap139.24M
Market cap139.24M
Price-Earnings ratio-1.85
Price-Earnings ratio-1.85
Dividend yield—
Dividend yield—
Average volume402.24K
Average volume402.24K
High today$12.99
High today$12.99
Low today$12.05
Low today$12.05
Open price$12.62
Open price$12.62
Volume413.46K
Volume413.46K
52 Week high$17.40
52 Week high$17.40
52 Week low$4.86
52 Week low$4.86
KZIA News
TipRanks 2d
Kazia Therapeutics Unveils Preclinical Breakthrough for Paxalisib in Immunotherapy-Resistant Colorectal CancerKazia Therapeutics ( (KZIA) ) has issued an update. On September 1, 2026, Kazia Therapeutics reported preclinical data showing its lead drug candidate paxalisi...
TipRanks 3d
Kazia Therapeutics Unveils New Investor-Focused WebsiteKazia Therapeutics ( (KZIA) ) has shared an announcement. On August 28, 2026, Kazia Therapeutics launched a new corporate website at www.kaziatx.com, replacing...
Analyst ratings
100%
of 6 ratingsBuy
100%
Hold
0%
Sell
0%
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.